Form 4 for ELV Elevance Health
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001156039-24-000026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +42.9K | 160.7K | +36% | $0 |
| D | 2024-03-05 | 2024-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | F - Tax | $499.11 | -19.3K | 117.8K | -14% | -$9.61M |
| D | 2024-03-05 | 2024-03-01 | ELV | BOUDREAUX GAIL | Pres, CEO, Dir | A - Grant | $0.00 | +32.5K | 32.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | A | A | 8,415 | $0.00 | 126,192 | D | — | — | (F2) Represents restricted share units. Restrictions lapse as follows: 2,805 shares each on 3/1/2025, 3/1/2026, and 3/1/2027. |
| 2 | Common | Common Stock | 2024-03-01 | A | A | 34,517 | $0.00 | 160,709 | D | — | — | (F3) Represents performance based restricted share units. Restrictions lapse on 3/1/2024. (F4) Balance includes 392.27 shares acquired on 3/24/2023, 389.71 shares acquired on 6/23/2023 and 388.21 shares acquired on 9/23/2023 through a dividend reinvestment plan. |
| 3 | Common | Common Stock | 2024-03-01 | F | D | 19,256 | $499.11 | 117,777 | D | — | — | (F1) PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2024-03-01 | A | A | 32,480 | $0.00 | 32,480 | D | $499.11 · — to 2034-03-01 | 32,480 Common Stock | (F5) The option represents a right to purchase a total of 32,480 shares, and is exercisable in one installment of 10,826 shares and two installments of 10,827 shares each, beginning on 3/1/2025, which is the one-year anniversary of the option grant date. |